As the weather gets nicer, more and more people will take their motorcycles onto roadways across the United States. Whether operating a motorcycle, car, or truck, a motorist is required to pay attention to others on the road. Although one driver may do everything right,…
Independence Day is many peoples’ favorite holiday, as everyone gets a chance to celebrate the founding of our nation with fireworks, barbeques, and loved ones. However, as the drinks flow and the celebrations continue, the country’s hospitals and first responders see an increased number of…
The Roundup Weed Killer cases are mounting against Monsanto, a unit under pharmaceutical behemoth Bayer AG. The active ingredient in Roundup, glyphosate, is a known carcinogen and can be a substantial contributing factor in causing cancer.
Proton pump inhibitors, or PPIs, are a type of medication most commonly used to treat gastrointestinal ailments such as heartburn, acid reflux, gastroesophageal reflux disease (GERD), gastritis, and ulcers in the stomach and esophagus.
According to a recent NPR report, soldiers who have used 3M earplugs reported hearing loss in both ears, as well as a persistent hearing defect known as tinnitus.
After increasing incidents of necrotizing fasciitis of the perineum reported among Type II diabetic patients taking SGLT2 inhibitors, the FDA is requiring the risk to be added to the prescribing information.
Thousands of American armed forces members are suffering from hearing loss and tinnitus because of defective earplugs supplied to the US Military by 3M Company.
Although the FDA has announced that it is reconsidering and overhauling its current expedited approval process for medical devices, the agency has not made any similar announcements regarding updates on its drug approval process.
A California Superior Court judge affirmed the judgment for Plaintiff Dewayne Johnson against Defendant Monsanto. This comes after a trial, which alleges Johnson's cancer was caused by years of exposure to Monsanto’s glyphosate-based weed-killer.
In a press release earlier this month, the FDA announced that it had voted 10-3 that they would push forward a contentious new pharmaceutical into the market despite warnings from Senators, NGOs and fellow FDA members. The new opiate, Dsuvia, is 10 times stronger than…
